BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12684522)

  • 21. Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-beta-lactamase from Fluoribacter gormanii, in native form and in complex with D-captopril.
    García-Sáez I; Mercuri PS; Papamicael C; Kahn R; Frère JM; Galleni M; Rossolini GM; Dideberg O
    J Mol Biol; 2003 Jan; 325(4):651-60. PubMed ID: 12507470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem.
    Garau G; Bebrone C; Anne C; Galleni M; Frère JM; Dideberg O
    J Mol Biol; 2005 Jan; 345(4):785-95. PubMed ID: 15588826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-beta-lactamase gene, blaB3, in the type strain, NCTC 10016.
    Woodford N; Palepou MF; Babini GS; Holmes B; Livermore DM
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1448-52. PubMed ID: 10817691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-beta-lactamases.
    Murphy TA; Catto LE; Halford SE; Hadfield AT; Minor W; Walsh TR; Spencer J
    J Mol Biol; 2006 Mar; 357(3):890-903. PubMed ID: 16460758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril analogues as metallo-β-lactamase inhibitors.
    Yusof Y; Tan DTC; Arjomandi OK; Schenk G; McGeary RP
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1589-1593. PubMed ID: 26883147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of IMP-2 metallo-β-lactamase from Acinetobacter spp.: comparison of active-site loop structures between IMP-1 and IMP-2.
    Yamaguchi Y; Matsueda S; Matsunaga K; Takashio N; Toma-Fukai S; Yamagata Y; Shibata N; Wachino J; Shibayama K; Arakawa Y; Kurosaki H
    Biol Pharm Bull; 2015; 38(1):96-101. PubMed ID: 25744464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, validation, and applications of anisotropic polarizable molecular mechanics to study ligand and drug-receptor interactions.
    Gresh N
    Curr Pharm Des; 2006; 12(17):2121-58. PubMed ID: 16796560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-β-Lactamase from Pseudomonas stutzeri.
    Booth MP; Kosmopoulou M; Poirel L; Nordmann P; Spencer J
    PLoS One; 2015; 10(10):e0140059. PubMed ID: 26451836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallo-beta-lactamases: two binding sites for one catalytic metal ion?
    Heinz U; Adolph HW
    Cell Mol Life Sci; 2004 Nov; 61(22):2827-39. PubMed ID: 15558212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of Serratia fonticola Sfh-I: activation of the nucleophile in mono-zinc metallo-β-lactamases.
    Fonseca F; Bromley EH; Saavedra MJ; Correia A; Spencer J
    J Mol Biol; 2011 Sep; 411(5):951-9. PubMed ID: 21762699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mono- and binuclear Zn2+-beta-lactamase. Role of the conserved cysteine in the catalytic mechanism.
    Paul-Soto R; Bauer R; Frère JM; Galleni M; Meyer-Klaucke W; Nolting H; Rossolini GM; de Seny D; Hernandez-Valladares M; Zeppezauer M; Adolph HW
    J Biol Chem; 1999 May; 274(19):13242-9. PubMed ID: 10224083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition.
    King DT; Worrall LJ; Gruninger R; Strynadka NC
    J Am Chem Soc; 2012 Jul; 134(28):11362-5. PubMed ID: 22713171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and biochemical characterization of a carbapenem-hydrolysing beta-lactamase from Flavobacterium johnsoniae.
    Naas T; Bellais S; Nordmann P
    J Antimicrob Chemother; 2003 Feb; 51(2):267-73. PubMed ID: 12562690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations.
    Oelschlaeger P; Schmid RD; Pleiss J
    Protein Eng; 2003 May; 16(5):341-50. PubMed ID: 12826725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing the role of Asp-120(81) of metallo-beta-lactamase (IMP-1) by site-directed mutagenesis, kinetic studies, and X-ray crystallography.
    Yamaguchi Y; Kuroki T; Yasuzawa H; Higashi T; Jin W; Kawanami A; Yamagata Y; Arakawa Y; Goto M; Kurosaki H
    J Biol Chem; 2005 May; 280(21):20824-32. PubMed ID: 15788415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Noncanonical Metal Center Drives the Activity of the Sediminispirochaeta smaragdinae Metallo-β-lactamase SPS-1.
    Cheng Z; VanPelt J; Bergstrom A; Bethel C; Katko A; Miller C; Mason K; Cumming E; Zhang H; Kimble RL; Fullington S; Bretz SL; Nix JC; Bonomo RA; Tierney DL; Page RC; Crowder MW
    Biochemistry; 2018 Sep; 57(35):5218-5229. PubMed ID: 30106565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L; Frénois F; Rybkine T; L'Hermite G; Petrella S; Delettré J; Jarlier V; Collatz E; Sougakoff W
    J Mol Biol; 2001 Jul; 310(4):859-74. PubMed ID: 11453693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor.
    Yamaguchi Y; Jin W; Matsunaga K; Ikemizu S; Yamagata Y; Wachino J; Shibata N; Arakawa Y; Kurosaki H
    J Med Chem; 2007 Dec; 50(26):6647-53. PubMed ID: 18052313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.